Evgeny Izumchenko
Consultant / Adviseur bij AYALA PHARMACEUTICALS, INC.
Profiel
Evgeny Izumchenko is an Assistant Professor in the Department of Medicine, Section of Hematology/Oncology, at the University of Chicago.
He is one of LongeVC's Advisory Board members.
Evgeny has performed thesis work in the laboratory of Dr Erica Golemis, an internationally recognised cancer biologist, and his studies provided some of the earliest insights on the role of NEDD9 in the early stages of cancer development.
He completed his first postdoctoral training with Dr Kevin Brown and Dr Stratford May at the University of Florida, with an NIH postdoctoral fellowship supporting his research.
Evgeny joined the lab of Dr David Sidransky at Johns Hopkins University in 2012, where he carried out seminal work in defining the clonal evolution and heterogeneity in several solid tumour types at both the genetic and epigenetic levels.
Based on his record of research accomplishments, he was invited to join the Department of Otolaryngology as an Instructor in 2016 and subsequently was promoted to the rank of Assistant Professor in May 2017.
Evgeny became a part of the Department of Medicine at the University of Chicago in 2019.
Evgeny holds a Bachelor's degree in Laboratory Medicine and a Master's degree in Clinical Biochemistry from the Ben-Gurion University of the Negev.
He received a Doctor of Philosophy (PhD) in Molecular Biology and Immunology via the BGU /Fox Chase Cancer Center (FCCC) Partnership Graduate Research Program from the Ben-Gurion University of the Negev.
Actieve functies van Evgeny Izumchenko
| Bedrijven | Functie | Begin |
|---|---|---|
| AYALA PHARMACEUTICALS, INC. | Consultant / Adviseur | 01-01-2017 |
InSilico Medicine, Inc.
 InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | Consultant / Adviseur | 01-01-2015 |
Y-Trap, Inc.
 Y-Trap, Inc. BiotechnologyHealth Technology Y-Trap, Inc. develops novel immunotherapy for cancer. The private company is located in the US. The American company was founded by Evgeny G Izumchenko. | Oprichter | 01-01-2015 |
LongeVC
 LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | Consultant / Adviseur | - |
Orisdx, Inc.
 Orisdx, Inc. Medical/Nursing ServicesHealth Services Orisdx, Inc. provides a saliva-based molecular detection method to check oral cavity pre-malignancies and cancers. The private company is based in Chicago, IL. The company was founded by Evgeny G Izumchenko. | Oprichter | 01-06-2021 |
Eerdere bekende functies van Evgeny Izumchenko
| Bedrijven | Functie | Einde |
|---|---|---|
Repair Biotechnologies, Inc.
 Repair Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Repair Biotechnologies, Inc. operates as a biotechnology company which develops clinic therapies. It specializes in developing reversing atherosclerosis and atrophy of the thymus. The company was founded by Reason Cherman and Bill Cherman in 2018 and is headquartered in Syracuse, NY. | Consultant / Adviseur | 01-11-2020 |
Opleiding van Evgeny Izumchenko
| Ben-Gurion University of the Negev | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AYALA PHARMACEUTICALS, INC. | Commercial Services |
| Bedrijven in privébezit | 5 |
|---|---|
Repair Biotechnologies, Inc.
Repair Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Repair Biotechnologies, Inc. operates as a biotechnology company which develops clinic therapies. It specializes in developing reversing atherosclerosis and atrophy of the thymus. The company was founded by Reason Cherman and Bill Cherman in 2018 and is headquartered in Syracuse, NY. | Commercial Services |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | Technology Services |
Y-Trap, Inc.
Y-Trap, Inc. BiotechnologyHealth Technology Y-Trap, Inc. develops novel immunotherapy for cancer. The private company is located in the US. The American company was founded by Evgeny G Izumchenko. | Health Technology |
LongeVC
LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | Finance |
Orisdx, Inc.
Orisdx, Inc. Medical/Nursing ServicesHealth Services Orisdx, Inc. provides a saliva-based molecular detection method to check oral cavity pre-malignancies and cancers. The private company is based in Chicago, IL. The company was founded by Evgeny G Izumchenko. | Health Services |
